Logo image of MMD

NYLI MACKAY DT MUNI OPPO FND (MMD) Stock Price, Quote, News and Overview

NYSE:MMD - New York Stock Exchange, Inc. - US56064K1007 - Currency: USD

15.65  +0.02 (+0.13%)

Fundamental Rating

1

Overall MMD gets a fundamental rating of 1 out of 10. We evaluated MMD against 0 industry peers in the Unkown industry. Both the profitability and financial health of MMD have multiple concerns. MMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MMD had positive earnings in the past year.
In the past year MMD had a positive cash flow from operations.
In multiple years MMD reported negative net income over the last 5 years.
Of the past 5 years MMD 4 years had a positive operating cash flow.
MMD Yearly Net Income VS EBIT VS OCF VS FCFMMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA -1.13%
ROE -1.77%
ROIC 1.59%
ROA(3y)-0.08%
ROA(5y)1.01%
ROE(3y)-0.29%
ROE(5y)1.52%
ROIC(3y)2.14%
ROIC(5y)2.21%
MMD Yearly ROA, ROE, ROICMMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Operating Margin of MMD has declined.
In the last couple of years the Gross Margin of MMD has declined.
Industry RankSector Rank
OM 51.63%
PM (TTM) N/A
GM 52.57%
OM growth 3Y-7.66%
OM growth 5Y-6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.11%
MMD Yearly Profit, Operating, Gross MarginsMMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for MMD remains at a similar level compared to 1 year ago.
MMD has more shares outstanding than it did 5 years ago.
MMD has a better debt/assets ratio than last year.
MMD Yearly Shares OutstandingMMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MMD Yearly Total Debt VS Total AssetsMMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that MMD is in the distress zone and has some risk of bankruptcy.
MMD has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as MMD would need 2.72 years to pay back of all of its debts.
A Debt/Equity ratio of 0.55 indicates that MMD is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.72
Altman-Z 0.58
ROIC/WACCN/A
WACCN/A
MMD Yearly LT Debt VS Equity VS FCFMMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.07 indicates that MMD may have some problems paying its short term obligations.
A Quick Ratio of 0.07 indicates that MMD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
MMD Yearly Current Assets VS Current LiabilitesMMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

MMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.10%, which is quite impressive.
The Revenue for MMD has decreased by -20.04% in the past year. This is quite bad
MMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.71% yearly.
EPS 1Y (TTM)123.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.95%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y-9.04%
Revenue growth 5Y-6.71%
Sales Q2Q%-15.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MMD Yearly Revenue VS EstimatesMMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MMD Yearly EPS VS EstimatesMMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.36, the valuation of MMD can be described as rather expensive.
MMD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 22.36
Fwd PE N/A
MMD Price Earnings VS Forward Price EarningsMMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.54
EV/EBITDA N/A
MMD Per share dataMMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

MMD has a Yearly Dividend Yield of 4.22%, which is a nice return.
MMD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.22%

5.2 History

The dividend of MMD decreases each year by -1.81%.
MMD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
MMD Yearly Dividends per shareMMD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MMD are negative and hence is the payout ratio. MMD will probably not be able to sustain this dividend level.
DP-328.08%
EPS Next 2YN/A
EPS Next 3YN/A
MMD Yearly Income VS Free CF VS DividendMMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

More info and screens

NYLI MACKAY DT MUNI OPPO FND

NYSE:MMD (2/21/2025, 8:04:00 PM)

15.65

+0.02 (+0.13%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.45%
Inst Owner Change-86.85%
Ins Owners0.04%
Ins Owner Change2.92%
Market Cap437.10M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 4.22%
Yearly Dividend0.98
Dividend Growth(5Y)-1.81%
DP-328.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.06)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.36
Fwd PE N/A
P/S 15.28
P/FCF 4.54
P/OCF 4.54
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)0.7
EY4.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.45
FCFY22.03%
OCF(TTM)3.45
OCFY22.03%
SpS1.02
BVpS16.97
TBVpS16.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.13%
ROE -1.77%
ROCE 3.12%
ROIC 1.59%
ROICexc 1.6%
ROICexgc 1.6%
OM 51.63%
PM (TTM) N/A
GM 52.57%
FCFM 336.53%
ROA(3y)-0.08%
ROA(5y)1.01%
ROE(3y)-0.29%
ROE(5y)1.52%
ROIC(3y)2.14%
ROIC(5y)2.21%
ROICexc(3y)2.16%
ROICexc(5y)2.22%
ROICexgc(3y)2.16%
ROICexgc(5y)2.22%
ROCE(3y)4.32%
ROCE(5y)4.28%
ROICexcg growth 3Y-9.77%
ROICexcg growth 5Y-9.59%
ROICexc growth 3Y-9.54%
ROICexc growth 5Y-9.59%
OM growth 3Y-7.66%
OM growth 5Y-6.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.11%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.72
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 0.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)123.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y-9.04%
Revenue growth 5Y-6.71%
Sales Q2Q%-15.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.93%
EBIT growth 3Y-16.01%
EBIT growth 5Y-12.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y197.16%
FCF growth 3YN/A
FCF growth 5Y65.99%
OCF growth 1Y197.16%
OCF growth 3YN/A
OCF growth 5Y65.99%